NDC 80005-113 – Etravirine
Etravirine 200 mg/1 · Tablet · Oral
Product NDC80005-113
Product details
- Brand name
- Etravirine
- Generic name
- Etravirine
- Labeler
- Carnegie Pharmaceuticals LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA215402
- Marketed since
- June 7, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Etravirine 200 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 80005-113-09 | 60 TABLET in 1 BOTTLE (80005-113-09) | Jun 7, 2022 |
Other Etravirine products
- 60219-1720 Etravirine 25 mg/1 · Tablet · Amneal Pharmaceuticals NY LLC
- 60219-1721 Etravirine 100 mg/1 · Tablet · Amneal Pharmaceuticals NY LLC
- 60219-1722 Etravirine 200 mg/1 · Tablet · Amneal Pharmaceuticals NY LLC
- 42291-473 Etravirine 100 mg/1 · Tablet · AvKARE
- 42291-474 Etravirine 200 mg/1 · Tablet · AvKARE
- 69452-254 Etravirine 100 mg/1 · Tablet · Bionpharma Inc.
- 69452-255 Etravirine 200 mg/1 · Tablet · Bionpharma Inc.
- 80005-112 Etravirine 100 mg/1 · Tablet · Carnegie Pharmaceuticals LLC
- 69315-285 Etravirine 100 mg/1 · Tablet · Leading Pharma, LLC
- 69315-286 Etravirine 200 mg/1 · Tablet · Leading Pharma, LLC
- 10147-0570 Etravirine 100 mg/1 · Tablet · Patriot Pharmaceuticals
- 10147-0571 Etravirine 200 mg/1 · Tablet · Patriot Pharmaceuticals